Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
01/31/1995 | US5385740 Biologically active material characterized by catabolic activity generally associated with cachexia-inducing tumors, preparations, production and uses thereof |
01/31/1995 | CA1334177C Production of chimeric antibodies by homologous recombination |
01/31/1995 | CA1334176C Monoclonal antibody recognizing gamma atrial natriuretic polypeptide |
01/30/1995 | CA2126523A1 Jak kinases and regulation of cytokine signal transduction |
01/27/1995 | CA2128547A1 Method for the separation of bacterial lipopolysaccharides from protein-containing solutions |
01/26/1995 | WO1995002701A1 Method of identifying human and animal cells capable of unlimited proliferation or tumour formation |
01/26/1995 | WO1995002612A1 Monoclonal antibodies to egg yolk immunoglobulins (igy) |
01/26/1995 | WO1995002421A1 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
01/26/1995 | WO1995002413A1 Suppression of inhibitors |
01/26/1995 | WO1994028125A3 Dna encoding prostaglandin receptor ep1 |
01/26/1995 | CA2167214A1 Monoclonal antibodies to egg yolk immunoglobulins (igy) |
01/26/1995 | CA2166976A1 Method for identifying human and animal cells having an unlimited proliferation or tumor-formation potential |
01/26/1995 | CA2166875A1 Transferrin receptor specific ligand-neuro-pharmaceutical agent fusion proteins |
01/25/1995 | EP0635575A1 Monoclonal antibodies against epitopes found in free but not in alpha-1-antichmotrypsin complexed prostate specific antigen |
01/25/1995 | EP0635271A1 Therapeutic kits against proteinacious mediators, method of preparation and pharmaceutical compositions containing them |
01/25/1995 | EP0635132A1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
01/25/1995 | EP0635068A1 Amplification of human mdm2 gene in human tumors |
01/25/1995 | EP0635064A1 Gustducin materials and methods |
01/25/1995 | EP0635056A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor |
01/25/1995 | EP0635054A1 Mammalian melanocyte stimulating hormone receptors and uses |
01/25/1995 | EP0635052A1 MONOCLONAL ANTIBODY TO CELL SURFACE PROTEIN OF THE BACTERIUM $i(STREPTOCOCCUS PNEUMONIAE) |
01/25/1995 | EP0635030A1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/$i(neu)) RELATED SURFACE ANTIGENS |
01/25/1995 | EP0635020A1 5(6)-methyl substituted fluorescein derivatives |
01/25/1995 | EP0635019A1 Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels |
01/25/1995 | EP0635016A1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof |
01/25/1995 | EP0635013A1 Novel barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels |
01/25/1995 | EP0635000A1 Novel phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels |
01/25/1995 | EP0634999A1 Novel amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels |
01/25/1995 | EP0634938A1 Immunotoxins directed against cd33 related surface antigens |
01/25/1995 | EP0634936A1 Materials and methods for immunocontraception |
01/25/1995 | EP0634896A1 Evaluation and treatment of patients with progressive immunosuppression |
01/24/1995 | US5384308 Lumicarmine |
01/24/1995 | US5384263 Method to produce immunodiagnostic reagents |
01/24/1995 | CA1334077C Monoclonal antibody recognizing human psti, hybridoma producing the antibody, and determination of human psti |
01/24/1995 | CA1334076C Monoclonal antibody recognizing atrial natriuretic polypeptide |
01/23/1995 | CA2128285A1 Monoclonal antibodies against prostate specific antigen that are not available in psa complexed to 1-antichymotrypsin |
01/20/1995 | CA2128151A1 Receptors of interleukin-12 and antibodies |
01/19/1995 | WO1995002054A2 Platelet glycoprotein v gene and uses |
01/19/1995 | WO1995002052A1 Mammamodulin, a hormone-independent mammary tumor cells specific protein |
01/19/1995 | WO1995001997A1 RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN |
01/19/1995 | WO1995001995A1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
01/19/1995 | WO1995001806A1 Pro-cytotoxic drug conjugates for anticancer therapy |
01/19/1995 | WO1995001801A1 Growth differentiation factor-6 |
01/19/1995 | WO1994026891A3 Purified mammalian flt3 ligands and agonists and antagonists thereof |
01/19/1995 | CA2166872A1 Platelet glycoprotein v gene and uses |
01/19/1995 | CA2166798A1 Pro-cytotoxic drug conjugates for anticancer therapy |
01/19/1995 | CA2165776A1 Growth differentiation factor-6 |
01/19/1995 | CA2141417A1 Mammamodulin, a hormone-independent mammary tumor cells specific protein |
01/18/1995 | EP0634161A1 Hair dye or cosmetic material, pretreatment agent and hair dyeing method |
01/18/1995 | EP0634018A1 Method of detecting microorganisms |
01/18/1995 | EP0633945A1 ANTIBODIES TO ALPHAvBETA3 INTEGRIN |
01/18/1995 | EP0633931A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
01/18/1995 | EP0633785A1 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
01/18/1995 | EP0603307A4 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same. |
01/18/1995 | EP0576623A4 Binding domains in notch and delta proteins. |
01/18/1995 | EP0394296B1 Assay of a body fluid for measuring bone resorption |
01/17/1995 | US5382521 Detection of cancer cells |
01/17/1995 | US5382515 Creative kinase-MB immunoassay for myocardial infarction and reagents |
01/17/1995 | US5382510 Methods of diagnosing pre-cancer or cancer states using probes for detecting mutant p53 |
01/17/1995 | US5382509 Method and kit for the diagnosis of human papillomavirus type 41 |
01/17/1995 | CA2128175A1 Determination of lymph nodes enriched in tumor reactive cells, their proliferation, and their use in adoptive cellular therapy |
01/12/1995 | WO1995001571A1 Process for the preparation of factor x depleted plasma |
01/12/1995 | WO1995001568A1 Immunoassay for soluble fibrin polymers |
01/12/1995 | WO1995001457A1 Htlv-iinra compositions and assays for detecting htlv infection |
01/12/1995 | WO1995001445A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto |
01/12/1995 | WO1995001441A1 Tuberculosis vaccine |
01/12/1995 | WO1995001438A1 Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof |
01/12/1995 | WO1995001437A2 Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
01/12/1995 | WO1995001431A1 Peptide family, designated as xenonins |
01/12/1995 | WO1995001155A1 Oral compositions |
01/12/1995 | CA2166401A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto |
01/12/1995 | CA2166386A1 Immunoassay for soluble fibrin polymers |
01/12/1995 | CA2166298A1 Peptide family, designated as xenonins |
01/12/1995 | CA2163979A1 Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof |
01/12/1995 | CA2143126A1 Process for the preparation of factor x depleted plasma |
01/11/1995 | EP0633313A1 Vaccine against lyme disease |
01/11/1995 | EP0633268A2 MDC proteins and DNAs encoding the same |
01/11/1995 | EP0633029A2 Further improvements relating to drug delivery systems |
01/11/1995 | EP0633028A1 Vaccine against lyme disease |
01/11/1995 | EP0632832A1 Protein kinases |
01/11/1995 | EP0632810A1 New biotinylation reagent |
01/11/1995 | EP0632729A1 Anti-zona pellucida antibodies for delivery of therapeutic agents to the ovary |
01/11/1995 | EP0598000A4 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb. |
01/11/1995 | EP0207090B1 Monoclonal antibodies and antigens for human non-small cell lung carcinomas |
01/10/1995 | US5380825 AZT immunoassays, derivatives, conjugates and antibodies |
01/10/1995 | US5380656 Chymopapain and method of purifying it on an inhibitory dipeptide affinity column |
01/10/1995 | US5380513 Methods for reducing non-target retention of immunoconjugates and metabolites thereof |
01/10/1995 | CA2126819A1 Kit and method for pretargeting |
01/05/1995 | WO1995000851A1 Method for the diagnosis and analysis of tumours |
01/05/1995 | WO1995000845A1 Mca assay/kit for detecting metal cations |
01/05/1995 | WO1995000670A1 Linear and branched peptides effective in diagnosing and detecting non-a, non-b hepatitis |
01/05/1995 | WO1995000659A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
01/05/1995 | WO1995000658A1 COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODIES AGAINST CD44v6 |
01/05/1995 | WO1995000651A1 Recombinant stratum corneum chymotryptic enzyme (scce) |
01/05/1995 | WO1995000650A1 Recombinant dnase b derived from streptococcus pyogenes |
01/05/1995 | WO1995000649A1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy |
01/05/1995 | WO1995000643A2 Human cell adhesion protein aamp-1 and uses thereof |
01/05/1995 | WO1995000642A1 Vertebrate apoptosis gene: compositions and methods |
01/05/1995 | WO1995000633A2 Construction and use of synthetic constructs encoding syndecan |
01/05/1995 | WO1995000552A1 Prostaglandin receptor ep3 and dna encoding it |